Reliability and validity of the Thai version of the PHQ-9 by Lotrakul, Manote et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Psychiatry
Open Access Research article
Reliability and validity of the Thai version of the PHQ-9
Manote Lotrakul*1, Sutida Sumrithe2 and Ratana Saipanish1
Address: 1Department of Psychiatry, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand and 2Department 
of Family Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand
Email: Manote Lotrakul* - ramlt@mahidol.ac.th; Sutida Sumrithe - rasda@mahidol.ac.th; Ratana Saipanish - rarsp@mahidol.ac.th
* Corresponding author    
Abstract
Background: Most depression screening tools in Thailand are lengthy. The long process makes
them impractical for routine use in primary care. This study aims to examine the reliability and
validity of a Thai version Patient Health Questionnaire (PHQ-9) as a screening tool for major
depression in primary care patients.
Methods: The English language PHQ-9 was translated into Thai. The process involved back-
translation, cross-cultural adaptation, field testing of the pre-final version, as well as final
adjustments. The PHQ-9 was then administered among 1,000 patients in family practice clinic. Of
these 1,000 patients, 300 were further assessed by the Thai version of the Mini International
Neuropsychiatric Interview (MINI) and the Thai version of the Hamilton Rating Scale for
Depression (HAM-D). These tools served as gold-standards for diagnosing depression and for
assessing symptom severity, respectively. In the assessment, reliability and validity analyses, and
receiver operating characteristic curve analysis were performed.
Results: Complete data were obtained from 924 participants and 279 interviewed respondents.
The mean age of the participants was 45.0 years (SD = 14.3) and 73.7% of them were females. The
mean PHQ-9 score was 4.93 (SD = 3.75). The Thai version of the PHQ-9 had satisfactory internal
consistency (Cronbach's alpha = 0.79) and showed moderate convergent validity with the HAM-D
(r = 0.56; P < 0.001). The categorical algorithm of the PHQ-9 had low sensitivity (0.53) but very
high specificity (0.98) and positive likelihood ratio (27.37). Used as a continuous measure, the
optimal cut-off score of PHQ-9 ≥ 9 revealed a sensitivity of 0.84, specificity of 0.77, positive
predictive value (PPV) of 0.21, negative predictive value (NPV) of 0.99, and positive likelihood ratio
of 3.71. The area under the curve (AUC) in this study was 0.89 (SD = 0.05, 95% CI 0.85 to 0.92).
Conclusion: The Thai version of the PHQ-9 has acceptable psychometric properties for screening
for major depression in general practice with a recommended cut-off score of nine or greater.
Background
Depressive illness constitutes a significant proportion of
all disabilities caused by mental disorders and has signifi-
cant public health and economic costs [1]. During the past
two decades, health care professionals have made major
progress towards the treatment of depressive disorders. A
few treatment approaches and guidelines have been devel-
oped and proven to be effective. The situation is different,
however, in developing countries where there are insuffi-
cient resources for treating mental disorders. There has
Published: 20 June 2008
BMC Psychiatry 2008, 8:46 doi:10.1186/1471-244X-8-46
Received: 20 September 2007
Accepted: 20 June 2008
This article is available from: http://www.biomedcentral.com/1471-244X/8/46
© 2008 Lotrakul et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Psychiatry 2008, 8:46 http://www.biomedcentral.com/1471-244X/8/46
Page 2 of 7
(page number not for citation purposes)
been little progress in improving treatment modalities [2].
In Thailand, most patients with mental disorders are often
treated by general practitioners (GPs) because the number
of psychiatrists in the country is still small. Moreover, peo-
ple are reluctant to seek help from a psychiatrist, because
of existing prejudices against psychiatric disorders. This
has been reported in studies from several countries [3-5].
Thus, GPs in Thailand, as in many other countries, play an
important role in taking care of patients with mental
heath problems.
Depression is frequently unrecognized and undertreated
in primary care, as it is often expressed in terms of somatic
symptoms and anxiety rather than typical depressive
symptoms [2,6]. The conditions are worse in developing
countries where GPs are faced with high patient loads. A
study in Thailand has shown that 72% of GPs see more
than 50 patients a day, making it difficult for them to care
for patients with mental illness effectively [7]. Because of
this challenge, case-finding instruments may play a crucial
role in assisting GPs in identifying depressive disorders in
their patients.
During the last few years, a few depression screening ques-
tionnaires have been developed in the Thai language.
These include the Health-Related Self-Report (HRSR)
scale [8], the Thai Depression Inventory (TDI) [9] and the
Center for Epidemiological Studies Depression Scale
(CES-D) [10]. Despite their good sensitivity and fair to
good specificity, these questionnaires are too time-con-
suming or too burdensome for routine use in primary care
due to the large number of items on their lists. There is
thus a need for a case finding questionnaire that is brief
and easy to administer. Such a questionnaire can improve
the recognition of depression in primary care.
Recently, the nine-item Patient Health Questionnaire
(PHQ-9), which is derived from the Primary Care Evalua-
tion of Mental Disorders (PRIME-MD), has been used as
a reliable depression screening tool in primary care, with
a demonstrated good sensitivity and specificity for depres-
sive disorder. With only 9 items, the PHQ-9 is substan-
tially shorter than most other depression screening
measures. It comprises of 9 diagnostic symptom criteria
upon which the diagnosis of DSM-IV major depressive
disorder is based. With only 9 questions/items, the ques-
tionnaire has the potential to serve as a dual-purpose
instrument that establishes depressive disorder diagnoses
using a categorical algorithm as well as grades the depres-
sive symptom severity [11]. The PHQ-9 has been trans-
lated into various languages. A number of studies on its
validity and reliability as a diagnostic measure as well as
its utility in assessing depression severity and in monitor-
ing treatment response have been published [12-15].
However, till now, the PHQ-9 had not been translated
and validated in Thai language. The purpose of this study
was to assess the reliability and validity of a Thai version
of the PHQ-9 for screening for major depressive disorder
in general practice.
Methods
Subjects and procedure
This study project was approved by the Ethics Committee
on Human Experimentation of the Faculty of Medicine
Ramathibodi Hospital. The patients were recruited
between October 2006 and February 2007 from the out-
patient clinic of the department of family medicine, Ram-
athibodi Hospital, Bangkok. This clinic functions as a
primary care clinic of the hospital.
Every fifth patients attending the outpatient clinic of the
department was invited to participate in the study while
they were waiting for consultation. Informed consents
were obtained after the aims and the objectives of the
study had been explained to the patients and they had
agreed to participate in the study. The data were collected
until 1,000 cases were obtained.
After completing the questionnaires, 300 of the patients
were then assessed for their depressive illness by a research
assistant. Convenience sampling was used to recruit the
sample. The research assistant was a clinical psychologist
who was trained to use the Thai version [16] of Mini Inter-
national Neuropsychiatric Interview (MINI), and the Thai
version [17] of Hamilton Rating Scale for Depression
(HAM-D). She was unaware of the patients' PHQ-9
results, and interviewed the patients until a total of 300
responses were attained.
Measures
The Thai version of the PHQ-9 was translated from the
original PHQ-9 [11]. We used the Thai version of the Mini
International Neuropsychiatric Interview (MINI) [16] as
the criterion standard for identifying the presence of
major depressive disorder, and the Thai version of Hamil-
ton Rating Scale for Depression (HAM-D) [17] as a gold-
standard measure of symptom severity.
Patient Health Questionnaire (PHQ-9)
The PHQ-9 is a self-report measure, consisting of 9 ques-
tions based on the 9 DSM-IV criteria for major depressive
episode. It refers to symptoms experienced by the patients
during the two weeks prior to answering the question-
naires. After obtaining permission from the copy right
holder, the PHQ-9 was translated following the guidelines
for cross-cultural adaptation of self-report measures [18].
The process included two independent forward transla-
tions of the original PHQ-9 into Thai, consensus between
translators on a forward translation, back-translation by a
bilingual English teacher, and a review of the back-trans-BMC Psychiatry 2008, 8:46 http://www.biomedcentral.com/1471-244X/8/46
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lation. Ten patients attending the out-patient department
were invited to complete and to give comments on the
pre-final version. Final modifications and adjustments
were made accordingly.
Unlike many other questionnaires, the original PHQ-9
uses simple statements without culture-specific phrases,
so there were only a few problems in the translation.
Among the problems we encountered was the translation
of particular words or phrases such as 'feeling down', 'fidg-
ety' and 'restless'. After some discussions, the investigators
were able to find phrases in Thai that conveyed approxi-
mately the same meanings.
Scores for each item in the PHQ-9 range from 0 (not at
all), to 1 (several days), 2 (more than half of the days) and
3 (nearly every day), while summed scores range from 0
to 27. The PHQ-9 can be used as a screening tool with rec-
ommended cut-off scores of ten or greater for the diagno-
sis of major depression [11]. It can also be used to
establish a diagnosis following a categorical algorithm. A
major depressive disorder is diagnosed if 5 or more of the
9 symptoms have been present at least more than half the
days of the past 2 weeks and 1 of these symptoms has
been either depressed mood or anhedonia.
Mini International Neuropsychiatric Interview (MINI)
The MINI, version 5, is a standardized clinical diagnostic
interview schedule for DSM-IV Axis-I disorders [19]. It can
be reliably administered by lay interviewers who have
appropriate training. The Thai version of MINI, which was
translated from the MINI, version 5, was used in this
study. In comparison with an interview done by a clini-
cian, the Thai version of MINI showed a high sensitivity of
0.92 and specificity of 0.93 for the diagnosis of current
major depressive episode [16]. The depression modules of
the schedule were used in the study as the gold standard
diagnostic tool.
Hamilton Rating Scale for Depression (HAM-D)
The HAM-D is a well accepted research tool for measuring
the severity of depression and the response to treatment
[20]. The Thai version of the HAM-D has good internal
consistency (alpha coefficients = 0.74). Its concurrent
validity, as compared to the Global Assessment Scale, is
also satisfactory (Spearman's correlation coefficient = -
0.82) [17].
Data analysis
The data obtained in this study was analyzed by the Statis-
tical Package for the Social Science 10 (SPSS 10). The
internal consistency of the PHQ-9 was measured by Cron-
bach's alpha coefficient. For validity analysis, we deter-
mined both criterion and convergent validity. Criterion
validity tests a scale's performance in comparison to a
gold standard. The Thai version of MINI, which is used for
the diagnosis of major depressive disorder was used as a
criterion standard. Convergent validity is present when a
scale behaves according to hypothesized relationships
between the two tests that presumably measure the same
construct. In this study we tested the association between
PHQ-9 and the HAM-D.
We determined the criterion validity of PHQ-9 by assess-
ing the psychometric properties of various cut-off scores
and of the categorical algorithm of the PHQ-9. The fol-
lowing test characteristics of the PHQ-9 compared with
the MINI were calculated: sensitivity, specificity, predic-
tive values and likelihood ratios. To determine the best
cut-off score, the receiver operating characteristic (ROC)
curve was constructed against the presence of major
depressive disorder by the MINI. The area under the curve
(AUC) was also calculated. To determine the convergent
validity, Pearson's correlation coefficient was used to
establish the relationship between the PHQ-9 and the
HAM-D.
Results
We excluded from the study 76 of the 1,000 respondents
who participated in the study and 21 of the 300 respond-
ents who were further assessed by the MINI and the HAM-
D due to incomplete data. The remaining 924 (92.4%)
and 279 (93%) cases were included in our analysis.
The mean age of the 924 participants was 45.0 years (SD
= 14.3). There were 681 females (73.7%) and 243 males
(26.3%). Sixty per cent of them were married and 37.7%
of them had graduated from secondary school. The socio-
demographic characteristics of the 279 respondents who
were further interviewed were not different from the pre-
vious group.
The mean PHQ-9 score of the 924 subjects was 4.93 (SD
= 3.75) with a range of 0 to 24. The median score was 4.0,
with a skewness of 0.99 (SD = +0.08). Most of the partic-
ipants (89.4%) had a low PHQ-score (score < 10). Only
1.9% scored 15 or higher (moderately severe depression)
[11]. The mean PHQ-9 score of the 297 subjects who were
assessed by the gold standard tools was 6.5 (SD = 4.29).
Reliability and item analysis
Cronbach's alpha for the total scale was 0.79. The mean
scores for all PHQ-9 items are shown in Table 1. Individ-
ual items of the PHQ-9 were scored on a scale of 0 to 3 for
symptom severity. Two items that were endorsed most fre-
quently were sleep problems and low energy. The item
that was endorsed the least was suicidal ideation. All
items, if deleted, would consistently decrease the total
scale alpha, except item 9 (suicidal ideation) which also
had the least item-total correlation (0.35).BMC Psychiatry 2008, 8:46 http://www.biomedcentral.com/1471-244X/8/46
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Validity analysis
The performance of the PHQ-9 against the diagnosis of
major depressive disorder by the Thai version of the MINI
as a criterion standard was examined. According to the
MINI, 19 patients (6.8%) met the diagnosis of major
depressive disorder. The mean PHQ-9 score for these
patients was 13.21 (SD = 4.61) whereas the mean score
for patients without the diagnosis of major depression
was 6.01 (SD = 3.84).
The validity of the PHQ-9 as a diagnostic tool, using a cat-
egorical algorithm, had a sensitivity of 0.53, a specificity
of 0.98, a positive predictive value (PPV) of 0.67, a nega-
tive predictive value (NPV) of 0.97, and a positive likeli-
hood ratio of 27.37. It was suggested that the threshold
for item 9 (suicidal ideation) be lower, from "more than
half the days" to "several days", in order to raise the sensi-
tivity of the questionnaire [11]. However, we found that
this approach yielded poorer results. Although the sensi-
tivity at the new threshold increased to 0.58, its specificity,
positive predictive value (PPV), and positive likelihood
ratio decreased to 0.96, 0.50 and 13.68, respectively.
Table 2 demonstrates the sensitivity, specificity, PPV, NPV
and likelihood ratio of different PHQ-9 thresholds in
diagnosing major depression. At the cut-off score of the
PHQ-9 of nine or greater, the sensitivity was 0.84 and the
specificity was 0.77. This threshold had a PPV of 0.21 and
a NPV of 0.99. The positive likelihood ratio was 3.71 at
this cut-off point. The ROC curve illustrates that the PHQ-
9 performed well in identifying patients with major
depressive disorder (Fig 1). The area under the curve
(AUC) in this study was 0.89 (SD = 0.05, 95% CI 0.85 to
0.92) which demonstrated a moderate accuracy [21].
To determine the convergent validity of the PHQ-9, the
total score of PHQ-9 was correlated with the HAM-D. The
Pearson's correlation coefficient between the PHQ-9 and
the HAM-D was 0.56 (p < 0.001). This indicated a positive
association of moderate strength between the two instru-
ments.
We divided the HAM-D score into 4 groups according to
the severity of depression [22]. We hypothesized that sub-
jects with major depression would have higher PHQ-9
scores compared to subjects with mild depression or no
depression. As shown in the Table 3, the group of patients
with major depression as diagnosed by the HAM-D had a
mean PHQ score of 14, followed by mean PHQ scores of
10.05 and 8.14 in patients with moderate depression and
mild depression, respectively. These differences among
Table 1: PHQ-9 item level values and item-total correlations (n = 924)
PHQ-9 item Mean SD Corrected item-total correlation Alpha if item deleted
1. Little interest or pleasure in doing things 0.67 0.66 0.54 0.76
2. Feeling down, depressed, or hopeless 0.61 0.69 0.61 0.75
3. Trouble falling or staying asleep, or sleeping too much 0.92 0.87 0.48 0.77
4. Feeling tired or having little energy 0.88 0.83 0.56 0.76
5. Poor appetite or overeating 0.67 0.78 0.45 0.78
6. Feeling bad about yourself – or that you are a failure 0.30 0.58 0.48 0.77
7. Trouble concentrating on things 0.48 0.68 0.45 0.77
8. Moving or speaking so slowly that other people could have noticed 0.30 0.55 0.45 0.78
9. Thoughts that you would be better off dead or of hurting yourself 0.09 0.34 0.35 0.79
Table 2: The performance of various PHQ-9 cut-off scores in detecting major depression
Cut-off score Sensitivity Specificity Positive predictive value Negative predictive value Likelihood ratio – 
positive
Likelihood ratio – 
negative
≥ 6 0.95 0.48 0.12 0.99 1.81 0.11
≥ 7 0.95 0.55 0.13 0.99 2.12 0.095
≥ 8 0.89 0.65 0.16 0.99 2.56 0.16
≥ 9 0.84 0.77 0.21 0.99 3.71 0.2
≥ 10 0.74 0.85 0.27 0.98 5.04 0.31
≥ 11 0.68 0.89 0.31 0.97 6.13 0.36
≥ 12 0.68 0.90 0.34 0.98 7.12 0.35
≥ 13 0.63 0.94 0.43 0.97 10.26 0.39
≥ 14 0.47 0.96 0.47 0.96 12.32 0.55
≥ 15 0.37 0.97 0.50 0.95 13.68 0.65BMC Psychiatry 2008, 8:46 http://www.biomedcentral.com/1471-244X/8/46
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the four PHQ-9 severity subscales were statistically signif-
icant (ANOVA: F = 31.91, df = 3, 275, p < 0.0001).
Discussion
The Thai version of PHQ-9 has several potential advan-
tages. It is shorter than other diagnostic tools available in
Thailand for identifying depression. It was primarily
developed for use in primary care settings and is the only
Thai questionnaire that has been tested in a primary care
sample. With this instrument, both the presence of clini-
cal depression and its degree of severity may be assessed.
In primary care settings, the screening tool used for detect-
ing the presence of depression alone may not be a reliable
indicator of depression-related impairment. Instruments
that can be used in both screening and scaling modes have
a particular advantage in that their weaknesses can be
compensated by each other [23].
The internal consistency of the PHQ-9 in this study (alpha
coefficient = 0.79) was lower than in the studies from the
United State (alpha coefficient = 0.79–0.89) [12,13].
However, its reliability was within the acceptable range.
For a self-report instrument to be reliable, it is suggested
that Cronbach's alpha be at least 0.70 [24]. The low mean
PHQ-9 score of 4.9 in our study, compared to the mean
scores of 6.0–6.5 in the US sample [12], may reflect a pos-
sible tendency in our patients to underreport symptoms
via self-report questionnaire compared to the semi-struc-
tured interview.
The patients in this study had high rates of endorsement
of somatic symptoms, i.e. sleep problems, low energy,
and poor appetite. This is consistent with results from our
previous study of depressed Thai patients, in which
patients mostly emphasized somatic symptoms when
they first reported their symptoms [25]. A recent study
from four different racial groups in the United Stated also
showed similar findings. Interestingly, the US subjects
had a higher mean score in somatic symptoms such as
sleep problems (0.96 to 1.37) and low energy (1.24 to
1.41) compared to our Thai samples (0.92 for sleep prob-
lems and 0.88 for low energy), whereas rates of endorse-
ment of emotional symptoms such as anhedonia between
our samples (0.67) and the US samples (0.56 to 0.89)
were not very different. Our results support Kirmayer's
argument [26] that subjects from countries that discour-
age expression of emotional distress do not report more
somatic symptoms than subjects from countries where
expression of emotional distress is accepted or even
encouraged.
Result of the PHQ-9 categorical algorithm for detecting
major depressive episodes showed that it provided a high
specificity. However, its sensitivity was poor (0.53), ren-
dering this algorithm less useful for screening purposes
than the cut-off score. On the other hand, its high positive
likelihood ratio (LR+) of 27.4 may make it a suitable
method for a diagnostic purpose.
When the PHQ-9 was examined as a continuous measure,
its validity was supported by the AUC value which sug-
gests a moderate accuracy of the questionnaire. The sensi-
tivity at the cut-off value of 9 or greater was 0.84 and the
specificity was 0.77. These values are within an acceptable
range. Sensitivity of screening instruments is considered
good when their range is 0.79–0.97 and when their specif-
The Receiver Operating Characteristic (ROC) curve of the  PHQ-9 versus the MINI for major depression diagnosis Figure 1
The Receiver Operating Characteristic (ROC) curve 
of the PHQ-9 versus the MINI for major depression 
diagnosis.
Table 3: Relationship between PHQ-9 mean scores and depression severity by HAM-D
HAM-D score [22] N Mean PHQ-9 SD 95% CI
No depression (0–7) 210 5.42 3.73 4.92–5.93
Mild depression (8–12) 36 8.14 2.98 7.13–9.15
Moderate depression (13–17) 20 10.05 3.87 8.24–11.86
Major depression (18 or greater) 13 14.00 4.93 11.02–16.98BMC Psychiatry 2008, 8:46 http://www.biomedcentral.com/1471-244X/8/46
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icity is 0.63–0.86 [27]. The low specificity of the summed
PHQ-9 score for diagnosing major depression is due to
the fact that it is possible to diagnose the disorder without
having either of the two cardinal symptoms of major
depression. As such, the summed score does not match
perfectly with the MINI, which is a structured diagnostic
interview based on DSM-IV criteria [28].
The cut-off score at this point yielded the low PPV (0.21)
and high NPV (0.99). Results form other studies of the
PHQ-9 showed PPV ranging from 0.31 to 0.51 (depend-
ing on the cut-off) [11]. The PPV is the probability of dis-
ease if the patient's test is positive, while NPV indicates the
probability that the patient is disease-free if the test is neg-
ative. A low PPV may indicate lower specificity, or a lower
disease prevalence in the population undergoing screen-
ing, or a combination of these factors [29]. In this study,
results may come from both low specificity (0.77) and
low disease prevalence (6.8%).
We determined the convergent validity of the PHQ-9 in
relation to the HAM-D. The satisfactory correlation
between these two scales confirmed the validity of the
PHQ-9. Recently, the PHQ-9 was also demonstrated to be
sensitive to change and responsive to treatment outcomes
over time and thus is a useful tool for monitoring treat-
ment progress [14,30,31].
Our study had several limitations. First, the study was con-
ducted in a university hospital; therefore, the respondents
may not be representative of the actual primary care
patients seen in a rural and remote area. That is, on aver-
age, the depressive patients in the family practice clinic of
Ramathibodi Hospital are less severe than the depressive
patients attending primary care in remote area. This is
because when they or their relatives think that their symp-
toms are severe, they may go to the psychiatric out
patients unit of Ramathibodi Hospital directly; whereas in
a rural hospital, there is no psychiatric out-patient unit. In
such a situation, all depressive patients have to attend the
primary care unit of the hospital in the rural area, no mat-
ter how severe they are. For this reason, the respondents at
the Ramathibodi Hospital may not exactly represent the
actual primary care patients seen at hospitals in rural and
remote areas. However, these patients with severe symp-
toms were only a small proportion of cases and our main
objective of the study was to assess the ability of the tool
to identify borderline cases of depression, which is a
major problem in primary care settings. Second, there was
a possibility that a proportion of participants might have
underreported their depressive symptoms on both the
PHQ-9 and the MINI clinical interview. Third, although
the Thai version of the MINI performed well in a validity
study, due to its highly structured instrument, it is still
possible that it overestimated or underestimated the rate
of depression in this study. Despite its potential short-
coming, however, the MINI was easy to understand
because it was structured in simple, lay language. Thus few
problems were encountered in the process of administer-
ing the instrument. This was also the case in the study of
Adewuya et al [32]. Fourth, the test-retest reliability of the
PHQ-9 was not assessed. Generally, this type of reliability
is used for measuring the stability of a scale over time, and
it is usually assessed after a short period of time. Unfortu-
nately, most of the participants only had follow up
appointments at the hospital at least one month after they
first took the test. This time period is too long to assess the
test-retest reliability.
Caution should be exercised that, although the PHQ-9 is
a valid and useful self-rating instrument for screening for
depression, routine usage of the questionnaire, in isola-
tion, may not improve the quality of care as anticipated.
Results from a review have revealed that the routine
employment of screening questionnaires for depression
alone has minimal impact on clinician's detection, man-
agement, and outcome of depression [33]. Moreover, in
developing countries, new psychiatric cases identified by
such instruments may be just an add-on burden to GPs
whose workload is already heavy. Financial and institu-
tional constraints in health care services should be taken
into account before adopting such service delivery pro-
grams in order to maintain successful care [34]. In a
region where there is a shortage of GPs, besides the benefit
of a case detecting tool, a structured approach that facili-
tates an increased role of non-medical staff, patients, and
family members may be more appropriate [35].
In summary, the Thai version of the PHQ-9 has acceptable
psychometric properties for screening for major depres-
sion in general practice with a recommended cut-off score
of nine or greater. Due to the low PPV in this study, further
clinical assessment is recommended if a test result is pos-
itive. Because the categorical algorithm of the PHQ-9
yielded low sensitivity, it is less suitable for a screening
purpose.
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